UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
|
October 17, 2008 |
|
Date of Report (Date of earliest event reported) |
|
SUMMER INFANT, INC. |
|
(Exact Name of Registrant as Specified in Charter) |
|
DELAWARE |
|
001-33346 |
|
20-1994619 |
|
(State or Other |
|
(Commission File Number) |
|
(IRS Employer |
|
Jurisdiction of Incorporation) |
|
|
|
Identification No.) |
1275 PARK EAST DRIVE
WOONSOCKET, RHODE ISLAND 02895
(Address of Principal Executive Offices) (Zip Code)
(401) 671-6550
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Dr. Marlene Kraus from the Board of Directors
On October 17, 2008, Summer Infant, Inc. (the “Company”) received written notice from Dr. Marlene Kraus of her decision to resign from the Board of Directors (the “Board”) of the Company, effective as of October 20, 2008. Dr. Kraus’ resignation was not the result of any disagreement with the Company. Dr. Kraus has served as the Chairman of the Board since 2007. Jason Macari, an existing director of the Company and its President and Chief Executive Officer, has been appointed to succeed Dr. Kraus as Chairman of the Board.
On October 22, 2008, the Company issued a press release regarding the resignation of Dr. Kraus and the appointment of Mr. Macari. A copy of the press release is attached as Exhibit 99.1 hereto.
|
Item 9.01. |
|
Financial Statements and Exhibits. |
||
|
|
|
|
||
|
(a) |
|
Financial Statements of Business Acquired. |
||
|
|
|
|
||
|
|
|
Not applicable. |
||
|
|
|
|
||
|
(b) |
|
Pro Forma Financial Information. |
||
|
|
|
|
||
|
|
|
Not applicable. |
||
|
|
|
|
||
|
(c) |
|
Shell Company Transactions. |
||
|
|
|
|
||
|
|
|
Not applicable. |
||
|
|
|
|
||
|
(d) |
|
Exhibits. |
||
|
|
|
|
||
|
Exhibit |
|
|
|
|
Number |
|
|
|
|
|
|
|
|
|
99.1 |
|
Press release from Summer Infant, Inc., dated October 22, 2008. |
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SUMMER INFANT, INC. |
|
|
|
|
|
|
|
|
|
|
Date: October 23, 2008 |
By: |
/s/ Joseph Driscoll |
|
|
|
Joseph Driscoll |
|
|
|
Chief Financial Officer |
3
EXHIBIT INDEX
|
Exhibit |
|
|
|
Number |
|
Description |
|
|
|
|
|
99.1 |
|
Press release from Summer Infant, Inc., dated October 22, 2008. |
4